In the case of Duchenne muscular dystrophy, which is caused by mutations in the dystrophin-coded gene, the gene therapies to replace, restore, or exon skipping of the affected gene have been developed and appear to be effective [23,24]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.